Associate Professor of Nanomedicine, Institute for Academic Medicine
Full Member, Research Institute
Weill Cornell Medical College
Dr. Shen earned his M.D. from Zhejiang University Medical School of Hangzhou, China in 1985, and his Ph. D. from the University of Texas at Houston in 1997. After completing a four-year postdoctoral fellowship at the National Cancer Institute, he worked on cancer drug development in the pharmaceutical industry. He returned to the University of Texas at Houston Medical School as an Assistant Professor before becoming a member of Houston Methodist Research Institute in 2010. He is currently an Associate Professor of Nanomedicine in Houston Methodist Institute for Academic Medicine in Houston, Texas. He is also an Assistant Professor of Cell and Developmental Biology in Weill Cornell Medical College in New York, New York.
Dr. Shen's research interest is on development of effective cancer therapeutics. His research team has designed and developed (1) an injectable nanoparticle generator platform for targeted delivery and in situ activation of prodrugs at the tumor lesion, (2) an inflammatory tumor vasculature-targeted delivery system for small molecule inhibitors and therapeutic siRNA, and (3) a highly potent therapeutic cancer nanovaccine platform. Researchers in the lab are applying these technology platforms to treat multiple cancer types.
Patent Number: AU2016243027, Nov 23 2017